1/10th of 1%

Quote

anonymous

Guest
That is about the total market share of Auryxia a year and half after launch, I just don't get it. I used to work in this field years ago, but am now retired. Its efficacy is very comparable to say, Renvela, but the drug all but eliminates the need for IV iron.
 








anonymous said:
That is about the total market share of Auryxia a year and half after launch, I just don't get it. I used to work in this field years ago, but am now retired. Its efficacy is very comparable to say, Renvela, but the drug all but eliminates the need for IV iron.
Click to expand...

Look at the last 6 months. It is a better indicator of growth. The early launch had a poorly planned message as well as an entitled sales force that underperformed as a whole.
 
















This launch has been a total failure ask any doctor. even if Auryxia gets another indication, it may be too late to save the sinking ship. Only thing that could possibly save it is another company buys Keryx
 








anonymous said:
This launch has been a total failure ask any doctor. even if Auryxia gets another indication, it may be too late to save the sinking ship. Only thing that could possibly save it is another company buys Keryx
Click to expand...
"Total failure" why? Cost? Ins coverage? Efficacy? the clinical trials look solid to me
 








anonymous said:
This launch has been a total failure ask any doctor. even if Auryxia gets another indication, it may be too late to save the sinking ship. Only thing that could possibly save it is another company buys Keryx
Click to expand...
As with many human beings, late-bloomers are a phenomenon. Doesn't mean they won't succeed, but they may take some time getting there. And, yes, there is plenty of time to get there. This company is financially sound, has a realistic vision, and finally has the resources in place to be successful. It's a good product. And they've done a good job with the expansion. A larger sales force comprised of experienced, talented, and motivated reps will make things happen. And kudos to the originals who laid the groundwork, stuck around, and see the improvements!
 








anonymous said:
As with many human beings, late-bloomers are a phenomenon. Doesn't mean they won't succeed, but they may take some time getting there. And, yes, there is plenty of time to get there. This company is financially sound, has a realistic vision, and finally has the resources in place to be successful. It's a good product. And they've done a good job with the expansion. A larger sales force comprised of experienced, talented, and motivated reps will make things happen. And kudos to the originals who laid the groundwork, stuck around, and see the improvements!
Click to expand...
I like your attitude skippy
 








Nicely put but I'm not so sure about the expansion. Mark my words half will be gone or looking by 3rd quarter.

anonymous said:
As with many human beings, late-bloomers are a phenomenon. Doesn't mean they won't succeed, but they may take some time getting there. And, yes, there is plenty of time to get there. This company is financially sound, has a realistic vision, and finally has the resources in place to be successful. It's a good product. And they've done a good job with the expansion. A larger sales force comprised of experienced, talented, and motivated reps will make things happen. And kudos to the originals who laid the groundwork, stuck around, and see the improvements!
Click to expand...
 
























The talent of the salesforce is strong, many experienced reps with renal background who are dedicated to making the product and company a success. Managed care coverage still presents a challenge in many areas, with high co-pays. Great product though - future looks good.
 








anonymous said:
No one has answered the question posed in this thread, why doesn't this drug sell?
Click to expand...

Alright, here's one major reason....... FMC. Fresenius is the 800 pound gorilla that does not want its IV iron sales to drop. Disagree if you want but many FMC clinics are joint venture meaning they are in business with many physician groups. FMC has restricted Auryxia access to patients. How are you supposed to get a doc to ruffle the feathers of a business partner when it's much easier to write another binder that is proven to work just as well? These reps are good reps. Look and any number of them and you will see a history of success. It's the dumb ass management team that has been put in place, that is the problem. First timers with their lofty, self appointed, titles. Edwards as a VP??? Come on man! Great choice Greg M. And you back fill with Tony??? The stupidity lies in Boston, not the sales force.
 








Top Bottom
Back
Quote